213 related articles for article (PubMed ID: 33564095)
21. PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice.
Qiu W; Wang X; Leibowitz B; Yang W; Zhang L; Yu J
Hepatology; 2011 Oct; 54(4):1249-58. PubMed ID: 21725994
[TBL] [Abstract][Full Text] [Related]
22. Lack of gp130 expression in hepatocytes attenuates tumor progression in the DEN model.
Hatting M; Spannbauer M; Peng J; Al Masaoudi M; Sellge G; Nevzorova YA; Gassler N; Liedtke C; Cubero FJ; Trautwein C
Cell Death Dis; 2015 Mar; 6(3):e1667. PubMed ID: 25741592
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial IRG1 traps MCL-1 to induce hepatocyte apoptosis and promote carcinogenesis.
Zhang L; Dong Y; Zhang L; Wang M; Zhou Y; Jia K; Wang S; Wang M; Li Y; Luo S; Lu S; Fan Y; Zhang D; Yang Y; Li N; Yu Y; Cao X; Hou J
Cell Death Dis; 2023 Sep; 14(9):625. PubMed ID: 37737207
[TBL] [Abstract][Full Text] [Related]
24. Hepatocyte-specific deletion of DDB1 induces liver regeneration and tumorigenesis.
Yamaji S; Zhang M; Zhang J; Endo Y; Bibikova E; Goff SP; Cang Y
Proc Natl Acad Sci U S A; 2010 Dec; 107(51):22237-42. PubMed ID: 21135245
[TBL] [Abstract][Full Text] [Related]
25. Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis.
Van TM; Polykratis A; Straub BK; Kondylis V; Papadopoulou N; Pasparakis M
J Clin Invest; 2017 Jun; 127(7):2662-2677. PubMed ID: 28628031
[TBL] [Abstract][Full Text] [Related]
26. Involvement of Mouse Constitutive Androstane Receptor in Acifluorfen-Induced Liver Injury and Subsequent Tumor Development.
Kuwata K; Inoue K; Ichimura R; Takahashi M; Kodama Y; Shibutani M; Yoshida M
Toxicol Sci; 2016 Jun; 151(2):271-85. PubMed ID: 26928356
[TBL] [Abstract][Full Text] [Related]
27. Berberine and S allyl cysteine mediated amelioration of DEN+CCl4 induced hepatocarcinoma.
Sengupta D; Chowdhury KD; Sarkar A; Paul S; Sadhukhan GC
Biochim Biophys Acta; 2014 Jan; 1840(1):219-44. PubMed ID: 23999088
[TBL] [Abstract][Full Text] [Related]
28. Hepatocyte-specific deletion of the antiapoptotic protein myeloid cell leukemia-1 triggers proliferation and hepatocarcinogenesis in mice.
Weber A; Boger R; Vick B; Urbanik T; Haybaeck J; Zoller S; Teufel A; Krammer PH; Opferman JT; Galle PR; Schuchmann M; Heikenwalder M; Schulze-Bergkamen H
Hepatology; 2010 Apr; 51(4):1226-36. PubMed ID: 20099303
[TBL] [Abstract][Full Text] [Related]
29. Hepatocellular carcinoma as extracolonic manifestation of Lynch syndrome indicates SEC63 as potential target gene in hepatocarcinogenesis.
Casper M; Weber SN; Kloor M; Müllenbach R; Grobholz R; Lammert F; Zimmer V
Scand J Gastroenterol; 2013 Mar; 48(3):344-51. PubMed ID: 23537056
[TBL] [Abstract][Full Text] [Related]
30. RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis.
Mayhew CN; Carter SL; Fox SR; Sexton CR; Reed CA; Srinivasan SV; Liu X; Wikenheiser-Brokamp K; Boivin GP; Lee JS; Aronow BJ; Thorgeirsson SS; Knudsen ES
Gastroenterology; 2007 Sep; 133(3):976-84. PubMed ID: 17854601
[TBL] [Abstract][Full Text] [Related]
31. Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure.
Hsu SH; Wang B; Kutay H; Bid H; Shreve J; Zhang X; Costinean S; Bratasz A; Houghton P; Ghoshal K
Am J Pathol; 2013 Dec; 183(6):1719-1730. PubMed ID: 24113455
[TBL] [Abstract][Full Text] [Related]
32. Extracellular ATP and Purinergic P2Y
Schulien I; Hockenjos B; van Marck V; Ayata CK; Follo M; Thimme R; Hasselblatt P
Cancer Res; 2020 Feb; 80(4):699-708. PubMed ID: 31822494
[TBL] [Abstract][Full Text] [Related]
33. Testosterone regulation of cyclin E kinase: A key factor in determining gender differences in hepatocarcinogenesis.
Pok S; Barn VA; Wong HJ; Blackburn AC; Board P; Farrell GC; Teoh NC
J Gastroenterol Hepatol; 2016 Jun; 31(6):1210-9. PubMed ID: 26574916
[TBL] [Abstract][Full Text] [Related]
34. Activation of SRY accounts for male-specific hepatocarcinogenesis: Implication in gender disparity of hepatocellular carcinoma.
Liu C; Ren YF; Dong J; Ke MY; Ma F; Monga SPS; Wu R; Lv Y; Zhang XF
Cancer Lett; 2017 Dec; 410():20-31. PubMed ID: 28942012
[TBL] [Abstract][Full Text] [Related]
35. Loss of hepatocyte ERBB3 but not EGFR impairs hepatocarcinogenesis.
Scheving LA; Zhang X; Stevenson MC; Weintraub MA; Abbasi A; Clarke AM; Threadgill DW; Russell WE
Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G942-54. PubMed ID: 26492920
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks.
Helms TH; Mullins RD; Thomas-Ahner JM; Kulp SK; Campbell MJ; Lucas F; Schmidt N; LeMoine DM; Getaneh S; Xie Z; Phelps MA; Clinton SK; Coss CC
Sci Rep; 2021 Feb; 11(1):3646. PubMed ID: 33574348
[TBL] [Abstract][Full Text] [Related]
37. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
38. The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation.
Chen CC; Kim KH; Lau LF
Oncogene; 2016 Mar; 35(10):1314-23. PubMed ID: 26028023
[TBL] [Abstract][Full Text] [Related]
39. Nelumbo nucifera leaf extract treatment attenuated preneoplastic lesions and oxidative stress in the livers of diethylnitrosamine-treated rats.
Horng CT; Huang CW; Yang MY; Chen TH; Chang YC; Wang CJ
Environ Toxicol; 2017 Nov; 32(11):2327-2340. PubMed ID: 28804948
[TBL] [Abstract][Full Text] [Related]
40. Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys.
Lapis K; Sarosi I; Bocsi J; Thorgeirsson UP
Lab Invest; 1995 Jun; 72(6):748-59. PubMed ID: 7540236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]